{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T16:22:17Z","timestamp":1786378937022,"version":"build-2736575974"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The causal relationship between hypertension, antihypertensive drugs and the risk of erectile dysfunction is still uncertain. We performed a univariable and multivariable Mendelian randomization study to investigate whether they are causally related to erectile dysfunction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Genetic variants associated with blood pressure were derived from the genome-wide association study meta-analysis of the UK Biobank and International Consortium of Blood Pressure (<jats:italic>N<\/jats:italic>\u2009=\u2009757,601). Summary association data for hypertension were obtained from the UK Biobank (<jats:italic>N<\/jats:italic>\u2009=\u2009463,010) and the FinnGen study (<jats:italic>N<\/jats:italic>\u2009=\u2009356,077). The summary statistics of erectile dysfunction were obtained from the European ancestry with 223,805 subjects. The SNP instruments used to assess the effect of the protein targets of antihypertensive drugs on erectile dysfunction were obtained from previous studys. Causal effects were estimated using the univariate Mendelian randomization method (inverse variance weighted, MR-Egger, weighted median, MR-PRESSO and Wald ratios) and the multivariate Mendelian randomization method. Sensitivity analyses were implemented with the Cochran's <jats:italic>Q<\/jats:italic>-test, MR-Egger intercept test, MR-PRESSO, and leave-one-out analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Univariate MR found that elevated diastolic blood pressure may increase the occurrence of erectile dysfunction (odds ratio [OR]\u2009=\u20091.012; 95% confidence interval [CI]: 1.000\u20131.024; <jats:italic>P\u2009<\/jats:italic>=\u20090.047). Genetically predicted hypertension is also associated with ED (For the FinnGen, OR\u2009=\u20091.106; 95% CI: 1.027\u20131.191; <jats:italic>P<\/jats:italic>\u2009=\u20090.008. For the UK Biobank, OR\u2009=\u20093.832; 95% CI: 1.410\u201310.414; <jats:italic>P\u2009<\/jats:italic>=\u20090.008). However, after adjusting for systolic blood pressure, diastolic blood pressure and hypertension using multivariate Mendelian randomization, only hypertension was causally associated with ED occurrence (For the FinnGen, OR\u2009=\u20091.103; 95% CI: 1.018\u20131.195; <jats:italic>P\u2009<\/jats:italic>=\u20090.017. For the UK Biobank, OR\u2009=\u20095.037; 95% CI: 1.601\u201315.846; <jats:italic>P\u2009<\/jats:italic>=\u20090.006). We found no evidence that the use of angiotensin-converting enzyme inhibitors, beta-blockers, calcium channel blockers, and thiazide diuretic increased the risk of erectile dysfunction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Genetically predicted hypertension increases the risk of erectile dysfunction, but we found no causal relationship between elevated systolic\/diastolic blood pressure and erectile dysfunction. We speculate that the relationship between elevated blood pressure and erectile dysfunction risk may be nonlinear. We found little evidence that antihypertensive drugs increase the risk of erectile dysfunction.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2023.1157467","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T05:13:20Z","timestamp":1686287600000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Genetically predicted hypertension, antihypertensive drugs, and risk of erectile dysfunction: a Mendelian randomization study"],"prefix":"10.3389","volume":"10","author":[{"given":"Cong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-long","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-jie","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-song","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan-chao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/j.1743-6109.2009.01601.x","article-title":"Age-related changes in general and sexual health in middle-aged and older men: results from the European male ageing study (EMAS)","volume":"7","author":"Corona","year":"2010","journal-title":"J Sex Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"107493","DOI":"10.1016\/j.pharmthera.2020.107493","article-title":"Pharmacology and perspectives in erectile dysfunction in man","volume":"208","author":"Mitidieri","year":"2020","journal-title":"Pharmacol Ther"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/and.12644","article-title":"Hypertension might be a risk factor for erectile dysfunction: a meta-analysis","volume":"49","author":"Ning","year":"2017","journal-title":"Andrologia"},{"key":"B4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11886-017-0889-z","article-title":"Evaluation and management of erectile dysfunction in the hypertensive patient","volume":"19","author":"Patel","year":"2017","journal-title":"Curr Cardiol Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s10557-021-07197-9","article-title":"Effects of major antihypertensive drug classes on erectile function: a network meta-analysis","volume":"36","author":"Farmakis","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2020.07.009","article-title":"Erectile dysfunction and adherence to antihypertensive therapy: focus on \u03b2-blockers","volume":"81","author":"Manolis","year":"2020","journal-title":"Eur J Intern Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000147951","article-title":"Erectile dysfunction after therapy with metoprolol: the Hawthorne effect","volume":"112","author":"Cocco","year":"2009","journal-title":"Cardiology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1001\/jama.288.3.351","article-title":"Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction","volume":"288","author":"Ko","year":"2002","journal-title":"JAMA"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/ije\/dyx207","article-title":"Mendelian Randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities","volume":"46","author":"Walker","year":"2017","journal-title":"Int J Epidemiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/ije\/dyw127","article-title":"Commentary: two-sample Mendelian randomization: opportunities and challenges","volume":"45","author":"Lawlor","year":"2016","journal-title":"Int J Epidemiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s12916-022-02483-1","article-title":"Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study","volume":"20","author":"Ardissino","year":"2022","journal-title":"BMC Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1003897","DOI":"10.1371\/journal.pmed.1003897","article-title":"Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: a Mendelian randomization analysis","volume":"19","author":"Yarmolinsky","year":"2022","journal-title":"PLoS Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41588-018-0205-x","article-title":"Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits","volume":"50","author":"Evangelou","year":"2018","journal-title":"Nat Genet"},{"key":"B15","year":""},{"key":"B16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ajhg.2018.11.004","article-title":"GWAS Identifies risk locus for erectile dysfunction and implicates hypothalamic neurobiology and diabetes in etiology","volume":"104","author":"Bovijn","year":"2019","journal-title":"Am J Hum Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/sim.9156","article-title":"Pleiotropy robust methods for multivariable Mendelian randomization","volume":"40","author":"Grant","year":"2021","journal-title":"Stat Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian Randomization with invalid instruments: effect estimation and bias detection through egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","article-title":"Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants","volume":"28","author":"Burgess","year":"2017","journal-title":"Epidemiology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"dyac233","DOI":"10.1093\/ije\/dyac233","article-title":"An empirical investigation into the impact of winner's Curse on estimates from Mendelian randomization","author":"Jiang","year":"2022","journal-title":"Int J Epidemiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/ajh\/hpaa143","article-title":"Hypertension and erectile dysfunction: breaking down the challenges","volume":"34","author":"de Oliveira","year":"2021","journal-title":"Am J Hypertens"},{"key":"B24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2164\/jandrol.04191","article-title":"Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared with normotensive subjects","volume":"27","author":"Doumas","year":"2006","journal-title":"J Androl"},{"key":"B25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jsxm.2018.12.007","article-title":"Blood pressure, sexual activity, and erectile function in hypertensive men: baseline findings from the systolic blood pressure intervention trial (SPRINT)","volume":"16","author":"Foy","year":"2019","journal-title":"J Sex Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jsxm.2019.01.011","article-title":"Tighter blood pressure control is associated with lower incidence of erectile dysfunction in hypertensive men","volume":"16","author":"Hsiao","year":"2019","journal-title":"J Sex Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1097\/HJH.0000000000002382","article-title":"Update of the position paper on arterial hypertension and erectile dysfunction","volume":"38","author":"Viigimaa","year":"2020","journal-title":"J Hypertens"},{"key":"B28","doi-asserted-by":"publisher","first-page":"ehz747.0405","DOI":"10.1093\/eurheartj\/ehz747.0405","article-title":"P806High normal blood pressure and vascular parameters in patients with erectile dysfunction","volume":"40","author":"Ioakeimidis","year":"2019","journal-title":"Eur Heart J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12471-013-0482-z","article-title":"A review of the positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice","volume":"22","author":"Nicolai","year":"2014","journal-title":"Neth Heart J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0035-1565100","article-title":"Sexual dysfunction related to drugs: a critical review. Part V: \u03b1-blocker and 5-ARI drugs","volume":"49","author":"La Torre","year":"2016","journal-title":"Pharmacopsychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/HCO.0000000000000189","article-title":"Antihypertensive therapy causes erectile dysfunction","volume":"30","author":"Chrysant","year":"2015","journal-title":"Curr Opin Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1157467\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T05:13:23Z","timestamp":1686287603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1157467\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":31,"alternative-id":["10.3389\/fcvm.2023.1157467"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1157467","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,9]]},"article-number":"1157467"}}